在电子健康记录中插入提示以促进遵守加州阿片类药物法律后的阿片类药物与纳洛酮处方
这项队列研究采用中断时间序列混合模型,评估加州Kaiser Permanente Southern California(KPSC)在2018年1月1日至2019年12月31日期间的数据,2018年12月27日在电子健康记录系统中整合了一系列基于AB 2760的电子提示。6515名符合条件的临床医生为500711名独特患者提供了1903289次门诊就诊并开具阿片类药物。主要结果显示,纳洛酮订单率从2018年12月的2.0%增至2019年1月的13.2%,并继续增至2019年12月的27.1%;实施提示后门诊阿片类药物处方率每处方者-月下降15.1%(RR 0.85;95% CI 0.83-0.87),每处方者-月总吗啡毫克当量下降7.8%(RR 0.92;95% CI 0.89-0.96)。其他安全处方措施也改善。研究提示,通过鼓励安全处方习惯可能减轻阿片类药物过量风险。
要点
- 在电子健康记录中整合基于AB 2760的提示后,纳洛酮订单率从2018年12月的2.0%升至2019年1月的13.2%,并继续升至2019年12月的27.1%。
- 实施提示后,门诊阿片类药物处方率每处方者-月下降15.1%(RR 0.85;95% CI 0.83-0.87),实施后趋势每处方者-月增加0.7%(RR 1.01;95% CI 1.01-1.01),但总体趋势仍在下降。
- 实施提示后,每处方者-月总吗啡毫克当量下降7.8%(RR 0.92;95% CI 0.89-0.96),实施后趋势逐渐减弱。
- 其他安全处方措施改善:伴随肌肉松弛剂订单减少(RR 0.94;95% CI 0.89-1.00)、初始阿片类药物订单减少(RR 0.86;95% CI 0.83-0.89)、续方阿片类药物订单减少(RR 0.65;95% CI 0.62-0.69)、长期高剂量订单减少(RR 0.96;95% CI 0.94-0.98)。
适用人群与场景
- 研究期间持续受雇于KPSC并在2018年为符合条件的患者开具阿片类镇痛药的临床医生。
- 研究期间接受阿片类镇痛药处方的18岁及以上KPSC成员。
- 门诊就诊场景。
诊断标准与关键阈值
- 电子提示在门诊就诊时满足1项或多项AB 2760定义的阿片类药物处方条件时触发或激活。
研究设计与关键结果
- 研究类型:队列研究,采用中断时间序列混合模型;数据来自Kaiser Permanente Southern California(KPSC),时间范围为2018年1月1日至2019年12月31日。
- 样本量:6515名符合条件的临床医生(平均[SD]年龄45.9[9.43]岁;3604名男性[55.3%]),为500711名独特患者(平均[SD]年龄60.4[15.67]岁;1121004名女性[58.9%])提供了1903289次门诊就诊并开具阿片类药物。
- 干预:2018年12月27日在KPSC电子健康记录系统中整合了一系列基于AB 2760的电子提示。
- 主要终点:纳洛酮订单率从2018年12月的2.0%增至2019年1月的13.2%,并继续增至2019年12月的27.1%;门诊阿片类药物处方率每处方者-月下降15.1%(RR 0.85;95% CI 0.83-0.87),实施后趋势每处方者-月增加0.7%(RR 1.01;95% CI 1.01-1.01),总体趋势仍在下降。
- 次要终点:每处方者-月总吗啡毫克当量下降7.8%(RR 0.92;95% CI 0.89-0.96),实施后趋势逐渐减弱;伴随肌肉松弛剂订单减少(RR 0.94;95% CI 0.89-1.00)、初始阿片类药物订单减少(RR 0.86;95% CI 0.83-0.89)、续方阿片类药物订单减少(RR 0.65;95% CI 0.62-0.69)、长期高剂量订单减少(RR 0.96;95% CI 0.94-0.98)。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,研究 findings 提示通过鼓励安全处方习惯可能减轻阿片类药物过量风险。
指南或共识出处
- California Assembly Bill (AB) 2760(2018年)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Opioid addiction or dependency is a serious crisis in the US that affects public health as well as social and economic welfare. The State of California passed Assembly Bill (AB) 2760 in 2018 that mandates the coprescription of naloxone and opioids for patients with a high overdose risk.
OBJECTIVE: To assess whether the AB 2760-based electronic prompts were associated with increased naloxone orders for opioid users and reduced opioid prescribing when integrated into the practitioner workflow.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used interrupted time series mixed models to evaluate data obtained from the regional integrated health care system Kaiser Permanente Southern California (KPSC) from January 1, 2018, to December 31, 2019. Clinician participants were continuously employed at KPSC during the study period and ordered an opioid analgesic for eligible patients in 2018. Patient participants were KPSC members aged 18 years or older who received an opioid analgesic prescription during the study period. A series of AB 2760-based electronic prompts were integrated into the KPSC electronic health record system on December 27, 2018. The prompts are triggered or activated when 1 or more opioid prescribing conditions, defined in the AB 2760, are met at outpatient visits. Data were analyzed from January 8, 2021, to September 15, 2021.
EXPOSURES: Assembly Bill 2760-based electronic prompts for outpatient opioid prescriptions in the electronic health record system.
MAIN OUTCOMES AND MEASURES: Primary outcomes were changes in outpatient naloxone order rates among patients who were prescribed opioids and changes in outpatient opioid prescribing rates. Secondary outcomes were total morphine milligram equivalents (MMEs) ordered per prescriber-month, prompts-targeted objectives, and unintended consequences. Risk for opioid abuse among 3 types of patients was also assessed.
RESULTS: The 6515 eligible clinicians (mean [SD] age, 45.9 [9.43] years; 3604 men [55.3%]) included in the study served 500 711 unique patients in 1 903 289 outpatient encounters (mean [SD] age, 60.4 [15.67] years; 1 121 004 women [58.9%]) in which an opioid analgesic was prescribed. Naloxone order rate increased from 2.0% in December 2018 to 13.2% in January 2019 and then continued to increase to 27.1% in December 2019. Outpatient opioid prescribing rates decreased by 15.1% (rate ratio [RR], 0.85; 95% CI, 0.83-0.87) per prescriber-month when the electronic prompts were implemented. The postimplementation trend increased by 0.7% per prescriber-month (RR, 1.01; 95% CI, 1.01-1.01); the overall trend was still decreasing. The total MMEs per prescriber-month decreased by 7.8% (RR, 0.92; 95% CI, 0.89-0.96) after implementation of the prompts. The postimplementation trend tapered off. Other safe opioid prescribing measures also improved after implementation (decreases in concomitant muscle relaxants orders [RR, 0.94; 95% CI, 0.89-1.00], initial [RR, 0.86; 0.83-0.89] and renewal [RR, 0.65; 95% CI, 0.62-0.69] opioid orders, and long-term high-dose orders [RR, 0.96; 95% CI, 0.94-0.98]).
CONCLUSIONS AND RELEVANCE: This study found an association between implementation of AB 2760-based prompts and increased naloxone order rate; improved opioid prescribing measures (ie, decreased concomitant muscle relaxants orders, initial and renewal opioid orders, and long-term high-dose orders), except monthly median MMEs; and reduced opioid prescribing. The findings suggest that opioid overdose risks can be mitigated by encouraging safe prescribing habits.
参考来源
- Duan L, Lee MS, Adams JL, et al. Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law. JAMA Netw Open. 2022. PMID: 35499826. doi:10.1001/jamanetworkopen.2022.9723
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。